Jingqin (Rosy) Luo, PhD

Primary Academic Title

Professor of Surgery, Division of Public Health Sciences, WashU Medicine

Research Interest

Statistical analysis of microarray gene expression data and proteomics data, ranging from power calculation to biomarker identification and patient classification.

Education

2001: MS, statistics, Renmin University, Beijing
2004: MS, statistics, Duke University, Durham, N.C.
2006: PhD, statistics, Duke University

Selected Research Publications

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.

Li YD, Giles DA, Huang Y, [...] Luo J, [...] Chheda MG
Nat Commun 2026

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Kong T, Mabry A, Highkin M, [...] Luo J, Ma CX
Nat Commun 2026

Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host.

Gonzalez-Aponte MF, Damato AR, Simon T, [...] Luo J, [...] Herzog ED
Cancer Cell 2025

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis.

Chouhan S, Sridaran D, Weimholt C, Luo J, [...] Mahajan NP
Nat Commun 2024

SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.

Chen L, Shi V, Wang S, [...] Luo J, [...] Markovina S
J Clin Invest 2023

View All Publications